Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 4Terminated 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Other hematologic neoplasm 1

Conditions

Neoplasms 1Leukemia, Myeloid, Acute 1Carcinoma, Non-Small-Cell Lung 1BRAF V600E Mutation 1

Interventions

Specimen Handling 334Magnetic Resonance Spectroscopy 334Radiotherapy 315Cyclophosphamide 295pembrolizumab 281Cisplatin 267Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 204Bevacizumab 186Gemcitabine 178venetoclax 172Radiosurgery 169Capecitabine 164Oxaliplatin 163fludarabine 161Nivolumab 156Paclitaxel 155Standard of Care 136Surveys and Questionnaires 130Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 124Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104Azacitidine 101atezolizumab 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × OTHER × Cobicistat × Clear all
NCT06610682 2025-12-10

Feasibility of CSF and Plasma ctDNA in BRAF-altered Glioma During Treatment With Plixorafenib

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Recruiting
15 enrolled

BRAF V600E Mutation

NCT05748093 2024-08-09

OSIBOOST 2

Maastricht University Medical Center

Phase 4 Recruiting
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05078671 2024-06-12

PROACTIVE

Radboud University Medical Center

Phase 4 Recruiting
160 enrolled
Tumor-Agnostic

Neoplasms

NCT06014489 2024-01-18

HO171

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 2 Recruiting
142 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡